Medicamen Organics Receives ₹87.5 Lakh Balance Consideration; Allots 10 Lakh Equity Shares
Medicamen Organics Limited has submitted a statutory auditor's certificate confirming receipt of the balance consideration of ₹87.50 lakh (25%) from Mr. Pradeep Kumar Jain on November 07, 2026. This pertains to the conversion of 10,00,000 warrants allotted on June 09, 2026, leading to the allotment of 10,00,000 equity shares at ₹35 per share (face value ₹10 plus premium of ₹25). The company had earlier received ₹2.625 crore (75%), completing the full ₹3.50 crore fundraise. The total ₹3.50 crore raised represents approximately 87.5% of its current market capitalization of ₹4 crore.
உச்சம் நம்பிக்கை
என்ன மாறியதுConversion of 10 lakh warrants into 10 lakh fully paid-up equity shares upon receipt of the final ₹87.5 lakh, concluding the ₹3.5 crore warrant issue.
ஏன் இது முக்கியம்Provides an immediate liquidity infusion of ₹87.5 lakh and expands the equity base, representing a significant fund inflow relative to the company's ₹4 crore market cap.
Balance consideration received: INR 87,50,000Total warrant consideration: INR 3,50,00,000Shares allotted: 10,00,000Issue price per share: INR 35Total fundraise vs Market cap: ~87.5%
📅 குறுகிய காலம்Trading volume and equity base will adjust for the new 10 lakh equity shares, which may marginally dilute existing shareholding.
📈 நீண்ட காலம்The additional equity capital supports liquidity amidst long working capital cycles and capital commitments like the Nepal associate facility.
⚠ அபாய எச்சரிக்கைகள்
- Equity dilution from the issuance of 10,00,000 fresh shares
- High trade receivables cycle (7-8 months) remains an ongoing operational headwind
👀 கவனிக்க வேண்டியவை
Track the deployment of the ₹3.50 crore proceeds, particularly towards the Nepal associate project and liquidity management, alongside the subsequent shareholding pattern updates.
